Cristiano Alessandri Selected Research

anti-endothelial cell antibody

3/2015	Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus.
1/2006	Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance.
1/2004	Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristiano Alessandri Research Topics

Disease

35	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2004
25	Rheumatoid Arthritis 07/2022 - 01/2004
19	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2022 - 06/2005
16	Autoimmune Diseases (Autoimmune Disease) 07/2021 - 06/2005
8	Inflammation (Inflammations) 02/2021 - 01/2006
6	Thrombosis (Thrombus) 10/2022 - 06/2005
6	Arthritis (Polyarthritis) 11/2021 - 01/2009
5	Psoriatic Arthritis 07/2021 - 01/2018
5	Systemic Scleroderma (Systemic Sclerosis) 05/2008 - 03/2003
4	Lupus Nephritis 04/2021 - 06/2011
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019 - 10/2010
4	Rheumatic Diseases (Rheumatism) 10/2018 - 11/2016
4	Psychotic Disorders (Schizoaffective Disorder) 03/2015 - 01/2004
3	COVID-19 07/2022 - 01/2020
3	Necrosis 05/2021 - 07/2017
3	Infections 01/2020 - 01/2004
3	Habitual Abortion (Recurrent Miscarriage) 01/2019 - 10/2010
3	Cognitive Dysfunction 01/2018 - 01/2012
3	Atherosclerosis 01/2017 - 05/2008
3	Mental Disorders (Mental Disorder) 11/2016 - 01/2004
3	Adult-Onset Still's Disease 06/2014 - 04/2011
2	Sjogren's Syndrome (Sjogren Syndrome) 01/2022 - 06/2009
2	Ankylosing Spondylitis 01/2018 - 03/2017
2	Disease Progression 01/2017 - 02/2008
2	Thrombophilia 07/2015 - 01/2014
2	Central Nervous System Lupus Vasculitis 06/2006 - 05/2004
1	Fever (Fevers) 11/2022
1	Pregnancy Complications 10/2022
1	Fabry Disease (Fabry's Disease) 04/2021
1	Proteinuria 04/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2021
1	Primary Ovarian Insufficiency 06/2020
1	Cytokine Release Syndrome 01/2020
1	Osteoarthritis 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2020
1	Peripheral Arterial Disease 01/2020

Drug/Important Bio-Agent (IBA)

37	AntibodiesIBA 01/2022 - 03/2003
18	Proteins (Proteins, Gene)FDA Link 02/2021 - 01/2005
15	AutoantibodiesIBA 01/2020 - 03/2003
8	Antiphospholipid AntibodiesIBA 10/2022 - 10/2010
7	AutoantigensIBA 10/2022 - 01/2005
7	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2014
6	CytokinesIBA 05/2021 - 05/2011
5	Rheumatoid FactorIBA 07/2022 - 01/2004
5	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 01/2012
5	Cardiolipins (Cardiolipin)IBA 01/2022 - 10/2010
5	Anti-Citrullinated Protein AntibodiesIBA 01/2020 - 01/2004
5	Peptides (Polypeptides)IBA 11/2018 - 01/2009
4	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2022 - 01/2014
4	Biological ProductsIBA 11/2021 - 01/2004
4	VimentinIBA 01/2021 - 10/2010
4	Immunoglobulin G (IgG)IBA 11/2016 - 01/2005
4	Interleukin-18 (Interleukin 18)IBA 06/2014 - 01/2004
3	Immunoglobulin M (IgM)IBA 07/2022 - 01/2006
3	apremilastIBA 07/2021 - 08/2018
3	Estrogen ReceptorsIBA 01/2018 - 03/2012
3	anti-endothelial cell antibodyIBA 03/2015 - 01/2004
2	B-Cell Activating FactorIBA 01/2022 - 11/2019
2	belimumabIBA 01/2022 - 07/2020
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2021 - 12/2014
2	Pharmaceutical PreparationsIBA 12/2021 - 01/2018
2	Antirheumatic Agents (DMARD)IBA 05/2021 - 01/2020
2	Immunoglobulin A (IgA)IBA 01/2021 - 01/2006
2	Caffeine (No Doz)FDA LinkGeneric 12/2020 - 10/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2020 - 05/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 02/2008
2	AntigensIBA 01/2020 - 06/2005
2	ImmunosorbentsIBA 01/2020 - 07/2017
2	GlucocorticoidsIBA 01/2019 - 07/2017
2	HMGB1 Protein (HMG1)IBA 01/2019 - 01/2017
2	Estrogens (Estrogen)FDA Link 01/2018 - 01/2016
2	Anti-Idiotypic AntibodiesIBA 01/2018 - 01/2018
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016 - 06/2011
2	cyclic citrullinated peptideIBA 08/2006 - 01/2004
2	SeptinsIBA 06/2006 - 01/2005
1	GTP Phosphohydrolases (GTPases)IBA 11/2022
1	AS 8IBA 09/2022
1	Janus Kinase InhibitorsIBA 05/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Annexin A5IBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	Lysosomal Membrane ProteinsIBA 01/2022
1	Propidium (Propidium Iodide)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2021
1	baricitinibIBA 05/2021
1	Janus KinasesIBA 05/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 04/2021
1	COVID-19 VaccinesIBA 01/2021
1	Coffee FDA Link 12/2020
1	Messenger RNA (mRNA)IBA 10/2020
1	Ferritins (Ferritin)IBA 07/2020
1	Triptorelin Pamoate (Trelstar)FDA Link 06/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 06/2020
1	3-acetylpyridine adenine dinucleotide (APAD)IBA 01/2020
1	alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA 01/2020
1	EnzymesIBA 01/2020
1	InterleukinsIBA 01/2020

Therapy/Procedure

5	Therapeutics 12/2021 - 01/2008